After trial data for a new medicine proved inconclusive, Sarepta Therapeutics joined with the parents of sick boys to persuade officials it helped.

Topics:  sarepta therapeutics   
BING NEWS:
  • FDA investigating deaths of patients who had gastric balloon procedure for obesity
    The U.S. Food and Drug Administration has alerted physicians and surgeons who treat obesity that it is investigating whether there is a link between gastric balloons ó a new-generation weight-loss device ó and the deaths of five patients.
    08/11/2017 - 1:07 am | View Link
  • Eteplirsen Approval Seen as Marking New Direction at FDA
    "She approved a drug not realizing that by approving the drug based on evidence that was so obviously inadequate many health insurance companies would just refuse to pay for it." Without insurance coverage, families have to pay $300,000 a year for the drug.
    12/28/2016 - 3:01 am | View Link
  • To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
    A couple of weeks ago, the big insurance company Anthem decided that it wouldn’t pay for Exondys 51, a drug that already had been approved by the Food and ... The drug costs $300,000 a year, and the evidence that it works is almost laughably thin.
    10/28/2016 - 9:06 am | View Link
  • More
BING SEARCH:
  • Kaiser Health News
    About KHN. Kaiser Health News (KHN) is a nonprofit news service covering health policy issues at the federal and state level. Our stories appear in media outlets ...
    09/18/2017 - 8:41 pm | View Website
  • Phillip Morris Introduces ‘Marlboro M’ Marijuana ...
    MORE NEWS Latest Newsflash3 Side Feature Phillip Morris Introduces ‘Marlboro M’ Marijuana Cigarettes. Phillip Morris, the world’s biggest cigarette producer ...
    09/18/2017 - 4:23 pm | View Website
  • SRPT Stock Price
    Sarepta shoots higher as sales of $300,000-a-year drug exceed expectations. Sarepta Therapeutics Inc. shares shot more than 13% higher in late trading Wednesday after ...
    09/17/2017 - 6:52 am | View Website
  • September2016
    How much has Medicare spent on the EpiPen since 2007? The latest example of high and rising prescription drug prices to attract significant media and ...
    09/14/2017 - 10:04 pm | View Website
  • Who will pay for CRISPR?
    A few years ago, Dutch drug company uniQure set up a plant in Lexington, Mass., to make a gene therapy called Glybera, at the time the most expensive drug in the world.
    06/26/2017 - 8:59 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News